Having trouble viewing this email? View in your browser.
ESCMID Logo

31 January 2017
WEEKLY NEWS

Dear colleagues,

The European Commission published a public consultation on a One Health Action Plan to support EU member states in the fight against antimicrobial resistance. The consultation consists of two separate surveys, a questionnaire for citizens and one for administrations, associations and other organisations active in AMR.

You may also send suggestions on concrete actions to ensure greater coherence in the fight against AMR or concrete examples of AMR data that are not currently collected within the EU to our Office info@escmid.org to be included in the survey ESCMID will be filling in. But we also encourage specialists in our network to have their institutions in their respective countries participate in the survey and to help distribute the questionnaire for citizens via the channels at your disposal.

On a different – but not entirely unrelated note – the European Medicines Agency and the European Food Safety Authority issued at the end of last week a joint scientific opinion on measures to reduce the need to use antimicrobial agents in animal husbandry in the European Union, and the resulting impacts on food safety.

Your ESCMID communications editors

 

EPASG news: conference on anti-infective PK/PD & newsletter

The ESCMID Study Group for PK/PD of Anti-Infectives together with the International Society of Anti-Infective Pharmacology are organizing the EPASG/ISAP conference on anti-infective pharmacogenetics and pharmacodynamics on 21 April 2017 in Vienna. The conference, which takes place right before ECCMID 2017, will bring together researchers and clinicians from various parts of the world to discuss pro and cons of current PK/PD strategies. You will find more information on the conference and on study grants in the EPASG newsletter.

› Read more
 

Registration for the Summer School in Germany from 1 - 8 July is open

The one-week course from 1 – 8 July 2017 in Borstel, Germany, is dedicated to postgraduate and continuing medical education. The programme covers a broad range of topics in clinical microbiology and infectious diseases and will interest young MDs at the end of their specialty training as well as biologists, pharmacists, PhD students and postdoctoral fellows working in the infection field.

› Read more
 

CMI highlight: Glucose homeostasis, nutrition, infections in critical illness

Researchers from Belgium review tight blood glucose control and early macronutrient restriction as strategies to reduce nosocomial infections and sepsis in the critically ill. Although the optimal blood glucose target remains to be defined and many controversies are waiting to be solved, common sense supports preventing severe hyperglycaemia in all critically ill patients. When adequate monitoring tools and expertise are available, targeting strict normoglycaemia is preferable for ICU patients. However, when these conditions are not fulfilled in clinical practice, an intermediate target is advisable for safety reasons. Whether early macronutrient restriction renders moderate hyperglycaemia less harmful remains to be further explored. Future research that dares to challenge the classical dogmas will pave the way for clinical progress in this complex area of medicine.

› Read more
 

Registration deadline for the MALDI-TOF MS course in Basel is 3 February

Mass spectrometry is significantly reducing time-to-identification of pathogens, and clinical microbiology is now moving beyond identification towards antibiotic resistance testing, direct specimen exploration and typing. Participants will learn about recent breakthroughs and current applications from leading scientists in the field of MALDI-TOF mass spectrometry. Moreover, the course aims to create networks between clinical microbiologists, basic researchers and allied professions and build capacity to facilitate multiple applications in this multidisciplinary field across Europe.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.